Follow
Andrew Gdowski
Andrew Gdowski
University of Texas at Austin Dell Medical School
Verified email at ascension.org
Title
Cited by
Cited by
Year
Current concepts in bone metastasis, contemporary therapeutic strategies and ongoing clinical trials
AS Gdowski, A Ranjan, JK Vishwanatha
Journal of Experimental & Clinical Cancer Research 36, 1-13, 2017
1482017
Optimization and scale up of microfluidic nanolipomer production method for preclinical and potential clinical trials
A Gdowski, K Johnson, S Shah, I Gryczynski, J Vishwanatha, A Ranjan
Journal of nanobiotechnology 16, 1-10, 2018
692018
Development of biodegradable nanocarriers loaded with a monoclonal antibody
A Gdowski, A Ranjan, A Mukerjee, J Vishwanatha
International Journal of Molecular Sciences 16 (2), 3990-3995, 2015
402015
Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain
AS Gdowski, A Ranjan, MR Sarker, JK Vishwanatha
Nanomedicine 12 (17), 2083-2095, 2017
372017
Curcumin-ER prolonged subcutaneous delivery for the treatment of non-small cell lung cancer
AP Ranjan, A Mukerjee, A Gdowski, L Helson, A Bouchard, M Majeed, ...
Journal of Biomedical Nanotechnology 12 (4), 679-688, 2016
322016
Nanobiosensors: role in cancer detection and diagnosis
A Gdowski, AP Ranjan, A Mukerjee, JK Vishwanatha
Infectious Diseases and Nanomedicine I: First International Conference …, 2014
272014
Emerging therapeutics for targeting Akt in cancer
A Gdowski, M Panchoo, TV Treuren, A Basu
Front Biosci (Landmark Ed) 21, 757-768, 2016
182016
Bioinspired nanoparticles engineered for enhanced delivery to the bone
AS Gdowski, JB Lampe, VJT Lin, R Joshi, YC Wang, A Mukerjee, ...
ACS applied nano materials 2 (10), 6249-6257, 2019
62019
FGFR inhibition augments anti–PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression
A Okato, T Utsumi, M Ranieri, X Zheng, M Zhou, LD Pereira, T Chen, ...
The Journal of Clinical Investigation 134 (2), 2024
32024
Undiagnosed liver fibrosis in patients undergoing pancreatoduodenectomy for pancreatic adenocarcinoma
A Gdowski, H Osman, U Butt, S Foster, DR Jeyarajah
World Journal of Surgery 41, 2854-2857, 2017
32017
Novel Use of Hypoxia-Inducible Polymerizable Protein to Augment Chemotherapy for Pancreatic Cancer
A Gdowski, H Hayatshahi, R Fudala, R Joshi, J Liu, JK Vishwanatha, ...
Pharmaceutics 14 (1), 128, 2022
22022
A bioinformatics approach to the design and engineering of biomimetic personalized nanoparticle therapy for bone metastatic prostate cancer
A Gdowski, A Ranjan, V Lin, J Lampe, J Vishwanatha
12017
A prototype for a machine-learning assisted image analysis tool for preclinical in vivo studies
AM Aji, TM Kierski, JD Rojas, H Morilak, OJ Kelada, KH Gessner, ...
Cancer Research 84 (6_Supplement), 2336-2336, 2024
2024
Enhanced detection and characterization of targetable EGFR and ERBB2 exon20 insertion mutations in urothelial carcinoma.
A Gdowski, KH Gessner, E Kounlavong, L Kim, RM Kemper, M Zhou, ...
Journal of Clinical Oncology 41 (16_suppl), e16500-e16500, 2023
2023
Process for engineering targeted nanoparticles
JK Vishwanatha, A Gdowski, AP Ranjan, A Mukerjee
US Patent App. 17/309,030, 2022
2022
Bioinformatic inspired nanoparticles engineered for enhanced delivery to the bone.
A Gdowski, A Ranjan, J Lampe, V Lin, YC Wang, A Mukerjee, ...
Journal of Clinical Oncology 37 (15_suppl), e14637-e14637, 2019
2019
Cancer Cell Membrane-Coated Biomimetic Nanoparticles for Cancer Therapy
R Patil, RP Joshi, AP Ranjan, A Gdowski, JK Vishwanatha
2019
MMP9 responsive molecular beacon-loaded nanovesicles for imaging and therapy for triple negative breast cancer
AP Ranjan, R Fudala, S Shah, A Gdowski, P Kumar, I Grycznski, ...
Cancer Research 78 (13_Supplement), 3721-3721, 2018
2018
Current landscape of immunotherapy clinical trials in prostate cancer
A Gdowski, J Lampe, A Ranjan, J Vishwanatha
2018
Bone Sectioning Technique for 3D Confocal Image Resolution and Capture of Dye-Loaded Nanotherapeutics
A Gdowski, A Ranjan, J Vishwanatha
2018
The system can't perform the operation now. Try again later.
Articles 1–20